Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. - Wikidata - awgldk - TriplyDB

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

http://www.wikidata.org/entity/Q35597930

about

KASL clinical practice guidelines: management of chronic hepatitis B Does antiviral therapy reduce complications of cirrhosis?Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis.Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.Current hepatitis B treatment guidelines and future research directions.Incidence of hepatocellular carcinoma in patients with chronic hepatitis B virus infection who have normal alanine aminotransferase values.Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients A novel system for predicting liver histopathology in patients with chronic hepatitis B Efficacy and resistance of entecavir following 3 years of treatment of Japanese patients with lamivudine-refractory chronic hepatitis B.Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.Antiviral therapy and resistance with hepatitis B virus infection.Management of chronic hepatitis B with nucleoside or nucleotide analogues: a review of current guidelines Evaluation of the patient with hepatitis B A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection.Natural history of chronic hepatitis B: phases in a complex relationship.Mutations within enhancer II and BCP regions of hepatitis B virus in relation to advanced liver diseases in patients infected with subgenotype B3 in Indonesia.Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B.Large variations in risk of hepatocellular carcinoma and mortality in treatment naïve hepatitis B patients: systematic review with meta-analyses Baseline HBV DNA level is the most important factor associated with virologic breakthrough in chronic hepatitis B treated with lamivudine.High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B.Upper limits of normal for serum alanine aminotransferase levels in Chinese Han population.Characteristics of chronic hepatitis B patients who underwent liver biopsies.Sero-prevalence and factors associated with Hepatitis B and C co-infection in pregnant Nigerian women living with HIV infection.Comparison of the antiviral effects of different nucleos(t)ide analogues in chinese patients with chronic hepatitis B: a head-to-head study.Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection Protein profiling in hepatocellular carcinoma by label-free quantitative proteomics in two west African populations Viral hepatitis B: clinical and epidemiological characteristics.Comparison of histologic characteristics of Chinese chronic hepatitis B patients with persistently normal or mildly elevated ALT Serum ceruloplasmin levels correlate negatively with liver fibrosis in males with chronic hepatitis B: a new noninvasive model for predicting liver fibrosis in HBV-related liver disease.Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.High rate of core promoter and precore mutations in patients with chronic hepatitis B.Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase Efficacy of tenofovir disoproxil fumarate therapy in nucleoside-analogue naive Iranian patients treated for chronic hepatitis B.

P2860

Q26752475-D1ED1F91-66AF-4895-82DE-AF97BFED4DAD Q26851410-4B4AAF90-789D-4581-994E-93FBD1459663 Q27000080-07FC9D5F-EA1D-4EFA-B3B8-7822C21E341E Q28088566-E2714A26-18BB-44C0-B9EC-FA476DFBEE0E Q28386713-16DB7F54-5E7F-4061-A754-ECE64C52A96D Q28741501-653C0645-1772-4A1F-BA01-133995E4CF70 Q30251618-4DFB782E-3A8C-4CD3-BDA4-BBEED2FE677E Q30368428-8B70CDD6-1CCF-49B3-A2B5-93314BC7F8AC Q30391932-2A0A886B-7688-4218-A0F1-55DD19F7766D Q30487002-5A702C47-C377-4965-9442-125C2BCDFD4F Q33388299-FF6C689F-3179-4097-9C1C-81E76CB571BF Q33391833-6ADDB9A2-DD09-4D7C-B5DB-2AFEE43A8249 Q33599576-09D65A13-FDEC-4EA1-9C61-D5E98E3B9165 Q33621252-D89A3E65-BD33-42FC-9946-5E3135D59062 Q33718935-B9FEF323-9399-4572-9BE5-C049AF9BC39E Q33718958-6A600FBE-BE74-4070-8835-47E74000BA3F Q33787531-D87E621C-C00D-4AB6-97A0-50D2CD4C9B97 Q33855708-B0251C4C-5332-4889-A6E2-C22D9D6137E4 Q33896660-36587428-B00D-4865-8641-3B79A8CA4FB6 Q33959934-B746F63C-8F9A-48C8-BC7E-47ACC10B04AC Q34036650-3702D8A8-6828-4602-8824-A4D11516A24D Q34077471-494DB315-9596-4B93-A0F1-9922542D949F Q34112196-BF341C3E-F263-4A25-86E1-0DA917A40370 Q34184642-5A3930F8-A638-4580-A9DA-1A835147AC52 Q34203972-A1CC6792-8043-4E60-9750-4CF7B1ECFF2F Q34382082-B010E8CA-E716-473B-BEB4-3FFDAED259AC Q34391308-0C3CFBA5-7D63-47C8-86CC-5D1AD0BEA805 Q34409744-BD6FA81E-B889-4B14-87E2-92EA106D40FA Q34414362-8AF19D39-632C-4E9E-A79E-CFD8FEB4C9C4 Q34496866-EFC0205D-0C68-41DA-B455-9D597750A844 Q34735876-3F1FF17B-AC33-42D6-9694-E71D6640BD27 Q34892826-FDD08A5A-E2BC-45E4-B8D0-7F6DCCD9F48B Q34918154-690354EF-A4AC-467E-9E65-215C70AB91BF Q34930389-308023C9-DA56-4351-B4C3-A8C92D2A7314 Q35049139-E1E751CD-48AE-4B99-ABEA-41496742385D Q35054972-4571A4BD-6F68-4140-BB68-7CB76F049BD0 Q35115406-B067F5D6-484F-4488-9343-69CCB98C61ED Q35288857-34A58C77-71B8-416F-94AD-8107B1B53EE5 Q35464781-C353F06A-CDA4-41C5-B454-0DC325F89C30 Q35671645-DA5C623E-AA51-472D-8EAE-BD6ED63A5A6E

P2860

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

http://www.wikidata.org/entity/Q35597930

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

@ast

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

@en

type

label

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

@ast

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

@en

prefLabel

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

@ast

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

@en

P1433

Q35597930-FF024C80-AE9F-4E3A-9713-86E1D05B0647

P1476

Q35597930-A3A74315-D040-4E9C-9A07-0A55D787B3D8

P2093

Q35597930-25AA6FA1-3F3B-491D-BECC-43C8D7B9FFC2

Q35597930-314A839D-DF8A-4FC5-B94E-6156E143526B

Q35597930-438D2823-7067-44FC-9CC1-8E18DC03349C

Q35597930-65ABC4E3-B2EF-45B4-9332-B554F23F14AC

Q35597930-81702B92-5F62-4551-BC26-230C7E046E22

Q35597930-870A40E5-6200-4897-94DC-48AFE23B5487

Q35597930-AD27B888-8E05-4A5E-BE03-87915974C3E7

Q35597930-EF6A2DE9-7193-4C61-AFCC-41241A665FA8

Q35597930-F439F9A4-C8B4-4C7F-863E-461DB89A302C

P2860

Q35597930-174C10AF-E9FC-4385-B11C-89FA7B2F7A36

Q35597930-1CF0FCC7-C8E5-4A24-9FE8-856AC4C49741

Q35597930-270E6FC8-D77C-4D62-B639-DD89D2F90D2D

Q35597930-2925ECB1-FE19-4660-A527-C9AA295848BD

Q35597930-5A8B8DE8-652D-4086-B551-2239DF1610EC

Q35597930-674FC7CB-0617-4699-B3BB-F0D8B7A62F9D

Q35597930-70546AD2-6C6A-44B6-9276-80F31840DA46

Q35597930-829C019B-8667-47F8-965B-3E73962BB643

Q35597930-9D52E81A-D937-4A91-9EC7-9BEA3C86CD19

Q35597930-B1465A9C-89FB-4A68-BD22-345C9877A515

P304

Q35597930-624E7292-465E-452F-BE2E-4057102EA90F

P31

Q35597930-115A98A8-64EF-4CB6-8905-CDAC2D317250

P356

Q35597930-BC3FC9AC-C84F-49BE-90C0-C4F3EB4FD79C

P407

Q35597930-070E4F40-4FDE-4BCD-AB73-1690C40E1E61

P433

Q35597930-34F33E09-D6A9-46D2-85D5-8C86FD14D8DD

P478

Q35597930-9BD3A5AD-74A5-493C-8CDC-5EA848121342

P577

Q35597930-B17730C8-3FD0-4374-8D55-6418B6BF6444

P5875

Q35597930-9DAC133E-F4C5-4D9D-A9BC-FBBE5167A453

P698

Q35597930-C3A22AE1-BFB2-4488-BD60-3C2AD24182A1

P932

Q35597930-9DCCF207-69C6-43F4-A3BB-D304348930A5

P356

GUT.2005.065136

P1433

P1476

Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

@en

P2093

A O-O Chan

http://www.w3.org/2001/XMLSchema#string

B C-Y Wong

http://www.w3.org/2001/XMLSchema#string

C-L Lai

http://www.w3.org/2001/XMLSchema#string

D K-H Wong

http://www.w3.org/2001/XMLSchema#string

H-J Yuan

http://www.w3.org/2001/XMLSchema#string

J C-H Yuen

http://www.w3.org/2001/XMLSchema#string

K-C Lai

http://www.w3.org/2001/XMLSchema#string

M-F Yuen

http://www.w3.org/2001/XMLSchema#string

W-M Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic hepatitis B virus infection in Asian countries.

Hepatitis B--an important public health issue.

Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study

Management of hepatitis B: 2000--summary of a workshop.

Asian-Pacific consensus statement on the management of chronic hepatitis B: an update.

EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version).

The natural history of hepatitis B virus infection.

Natural history of chronic hepatitis B virus infection: new light on an old story.

Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.

Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.

P304

1610-1614

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2005.065136

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2005-05-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7866575

http://www.w3.org/2001/XMLSchema#string

P698

15871997

http://www.w3.org/2001/XMLSchema#string

P932

1774768

http://www.w3.org/2001/XMLSchema#string